Month: January 2021

Lisa Conte and Andreea Porcelli were interviewed again this week on Innovators with Jane King regarding long-hauler syndrome in post-COVID-19 recovery patients and Jaguar’s plans to explore the possibility of obtaining conditional marketing authorization in Europe to support development and commercialization of crofelemer for the COVID-related indication. When discussing post-acute COVID-19 long-hauler symptoms during a […]

JAGX’s securities continue to be listed on Nasdaq Stock Exchange San Francisco, CA (January 22, 2021): Jaguar Health, Inc. (Nasdaq: JAGX) (“Jaguar” or the “Company”) today announced that on January 21, 2021 the Company received formal notice that Jaguar has regained compliance with the bid price requirement, as required by the decision of the Nasdaq Hearings […]

Andreea Porcelli, CEO of Swiss Growth Forum, will be a co-presenter on the webcast in her separate capacity as a sponsor of the proposed SPAC San Francisco, CA (January 21, 2021): Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”) announced today that the Company and a sponsor of the proposed Post Pandemic Recovery Equity special […]

San Francisco, CA (January 15, 2021): Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”) today provided the replay link for the Company’s January 14, 2021 investor webcast and a recap of the key points from the presentation.   To access the audio recording and slides from the webcast, click here.   “Due to the unprecedented volume […]